Early Investigator Travel Awards

Supporting the next generation of MSA researchers

Supporting Early Career MSA Researchers

The MSA Coalition provides travel awards to defray costs of attending medical and scientific congresses in order to help attract talented early career investigators to the field of multiple system atrophy research. Many of the early career investigators who have received MSA Coalition Travel Awards are continuing to contribute important findings to the overall knowledge of MSA.

Early Investigator Travel Awards

The MSA Coalition offers a limited number of travel awards to early career investigators in order to defray the costs associated with travel to make a scientific presentation about Multiple System Atrophy at a conference, symposium or other professional meeting.

This travel funding opportunity is open to eligible applicants from all countries.

Travel awards (up to $2000) from the MSA Coalition are now available for conferences where Multiple System Atrophy will be a topic.

  • Note that your conference abstract or presentation must mention multiple system atrophy to be eligible.
  • Awardees must display the MSA Coalition logo on their poster or slide presentation.
  • Travel receipts and proof of conference attendance are required.
  • A written report from the conference must be submitted after your attendance.

Contact pbower@msacoalition.org for full eligibility details and an application form.

Tentative Application deadlines:
(Note: These dates are a general guide. Since proof of abstract submission is required to apply, the below application deadlines may be subject to change in order to accommodate abstract submission dates at specific conferences.)

Feb 1, 2020 (for conferences between May 2020 – Aug 2020)

Jun 1, 2020 (for conferences between Sep 2020 – Dec 2020)

Oct 1, 2020 (for conferences between Jan 2021 – Apr 2021)

** Note: These travel awards may not be available for conferences where the MSA Coalition is already providing sponsorship funds to cover travel awards administered directly by the conference organizers. Contact us first to check for eligible conferences and to verify application deadlines which may change to accommodate abstract submission dates at specific conferences.

 

Early Investigator Travel Awards Past Recipients

2019

International Conference on Alzheimer’s and Parkinson’s Diseases, Lisbon, Portugal:

Jay Shukla, Florey Institute, Melbourne, Australia
Role of iron and copper in alpha-synuclein mediated neurodegeneration in a mouse model of multiple system atrophy

Alpha-Synuclein Congress, Porto, Portugal:

Jonas Folke, University Hospital of Copenhagen, Denmark
Peripheral immune cells correlate to disease progression in Multiple System Atrophy and Parkinson’s Disease

Conceicao Bettencourt, Queens Square Brain Bank, University College of London, UK
DNA methylome analysis in post-mortem brain tissue of multiple system atrophy patients

Movement Disorder Society Congress, Nice, France:

Alexandra Perez Soriano, Hospital Clinic of Barcelona, Spain
Unravelling biological processes implicated in MSA and PD by transcriptomic analysis

Annamaria Vallelunga, University of Salerno, Italy
Serum MIR-96-5P and MIR-339-5P as a potential biomarker for Multiple System Atrophy and Parkinson’s Disease

Olivia Roman, Vanderbilt University, Nashville, TN USA
Neuromelanin-MRI in patients with Pure Autonomic Failure

Ashwin Sreelatha, University of Tuebingen, Germany
A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson’s disease

Society for Neuroscience Congress, Chicago, USA:

Karl Biggs, University of California Los Angeles, CA USA
Development of a novel ELISA method for quantification of phosphorylated S129 alpha-synuclein in biological samples

Miguel Lemos, Medical University of Innsbruck, Austria
Combined anti-alpha-synuclein therapy for disease modification in multiple system atrophy

American Neurological Society Annual Meeting, St. Louis, USA:

Shunsuke Koga, Mayo Clinic, Jacksonville, FL USA
Clinicopathologic features and antemortem diagnoses of multiple system atrophy: review of 170 autopsy-confirmed patients with MSA

2018

European Federation of Autonomic Societies, Vienna, Austria:

Cecilia Raccagni, Medical University of Innsbruck, Austria
The role of sensor-based gait analysis in differentiating idiopathic from atypical parkinsonism including gender aspects

Synuclein Conference, Lausanne, Switzerland:

David Marmion, Rush University Medical Center, Chicago, IL USA
Viral Vector-Mediated Rat and Nonhuman Primate Models Multiple System Atrophy

Movement Disorder Society Congress, Hong Kong:

Tomaz Rus, University Medical Center Ljubljana, Slovenia
Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

Johannes Levin, Ludwig-Maximilians-University, Munich, Germany
PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

Society for Neuroscience Congress, San Diego, USA:

Danielle Bouquio, University of California Los Angeles, CA USA
Treatment with the molecular tweezer, CLR01, shows positive efficacy in a multiple system atrophy mouse model

Se Hee Oh, Mayo Clinic, Jacksonville, FL USA
Mesenchymal stem cells modulate seeding with vesicle-associated α-synuclein in Parkinson’s disease

Rasmus Rydbirk, University Hospital of Copenhagen, Denmark
Epigenome-wide association study on prefrontal cortex tissue from multiple system atrophy patients shows indications of an activated immune system

2017

Movement Disorder Society Congress, Vancouver, Canada:

Roberto De Marzi, Medical University of Innsbruck, Austria
Putaminal Diffusion Imaging for the differential diagnosis of the parkinsonian variant of multiple system atrophy from Parkinson’s Disease: Impact of segmentation accuracy

Anna Maria Vallelunga, University of Salerno, Italy
Serum MIR-30C as a potential biomarker to discriminate MSA from PD patients: a pilot study

Society for Neuroscience Congress, Washington, DC USA:

Violetta Refolo, Medical University of Innsbruck, Austria
Microglial activation and markers of neuroinflammation in a transgenic mouse model of multiple system atrophy: insights into the pathogenesis of selective striatonigral degeneration

Suman Dutta, University of California, Los Angeles, CA USA
Analysis of neuron and oligodendroglia derived blood exosomes for diagnostics of synucleinopathies

Guadalupe Vidal-Martinez, Texas Tech University, El Paso, TX USA
Preclinical assessment of an FTY720-derivative, FTY720-Mitoxy as a potential novel therapy for multiple system atrophy

2016

Movement Disorder Society Congress, Berlin, Germany:

Giulia Giannini, University of Bologna, Italy
Early stridor onset predicts survival in Multiple System Atrophy

Serena Venezia, Medical University of Innsbruck, Austria
Targeting TLR4 for disease modification in multiple system atrophy: experimental evidence

Society for Neuroscience Congress, San Diego, USA:

Lorenz Haertner, Medical University of Innsbruck, Austria
Establishment of predictive validity in the PLP αSYN mouse model utilizing spectral parameters

2015

Society for Neuroscience Congress, Chicago, USA:

Fares Bassil, University of Bordeaux, France
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy